Cargando…
Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor’s Perspective
INTRODUCTION: Evidence-based clinical data on coronavirus disease 2019 (COVID-19) pharmacotherapies are scarce. OBJECTIVE: This study documented and characterized COVID-19 cases reported in individuals receiving treatment with Pfizer pharmaceutical products and cases that reported use of Pfizer phar...
Autores principales: | Beyzarov, Elena, Chen, Yan, Julg, Rob, Naim, Karen, Shah, Jigna, Gregory, William W., Ayoub, Ayman, Caubel, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755229/ https://www.ncbi.nlm.nih.gov/pubmed/33354753 http://dx.doi.org/10.1007/s40264-020-01035-x |
Ejemplares similares
-
Reporting of COVID-19 Reinfection and Potential Role of Immunosuppressant/Immunomodulating Agents: A Cross-Sectional Observational Analysis Based on a Spontaneous Reporting Database
por: Beyzarov, Elena, et al.
Publicado: (2022) -
Building an Evidence Base on the Place of Industry-Sponsored Programs in Drug Safety Surveillance
por: Arlett, Peter
Publicado: (2019) -
Photovoltaic Safety Conference Sponsored By The Solar Energy Research Institute
por: Luft, Werner
Publicado: (1988) -
EU co-sponsored research on accident management measures risk assessment and safety culture: final summary reports - 'AMM' cluster projects
por: Van Goethem, G, et al.
Publicado: (2001) -
Sponsor Acknowledgement
Publicado: (2015)